Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Denis Curtin

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
European Geriatric Medicine|October 11, 2023
Authors' response to points raised by Boland et al. regarding STOPP/START version 3 criteriaDenis O'Mahony, Antonio Cherubini, Anna Renom Guiteras, et al.
European Geriatric Medicine|February 28, 2024
Response to letter by Masse O et al. STOPP/START version 3: clinical pharmacists are raising alarmsDenis O'Mahony, Antonio Cherubini, Anna Renom Guiteras, et al.
European Geriatric Medicine|May 31, 2023
STOPP/START criteria for potentially inappropriate prescribing in older people: version 3Denis O'Mahony, Antonio Cherubini, Anna Renom Guiteras, et al.
European Geriatric Medicine|June 16, 2023
Correction: STOPP/START criteria for potentially inappropriate prescribing in older people: version 3Denis O'Mahony, Antonio Cherubini, Anna Renom Guiteras, et al.
European Geriatric Medicine|June 10, 2026
Response to Boland et al. "Appraisal of the references supporting STOPP/START version 3 criteria"Denis O'Mahony, Antonio Cherubini, Anna Renom Guiteras, et al.
Stroke|July 3, 2010
Stroke subtype classification to mechanism-specific and undetermined categories by TOAST, A-S-C-O, and causative classification system: direct comparison in the North Dublin population stroke studyMichael Marnane, Caroline A Duggan, Orla C Sheehan, et al.
JAMA Network Open|July 27, 2022
Comparison of 6 Mortality Risk Scores for Prediction of 1-Year Mortality Risk in Older Adults With MultimorbidityClaudio Schneider, Carole E Aubert, Cinzia Del Giovane, et al.
European Geriatric Medicine|July 29, 2020
Association of polypharmacy and hyperpolypharmacy with frailty states: a systematic review and meta-analysisKatie Palmer, Emanuele R Villani, Davide L Vetrano, et al.
Global Change Biology|April 21, 2015
Effects of climate change on the delivery of soil-mediated ecosystem services within the primary sector in temperate ecosystems: a review and New Zealand case studyKate H Orwin, Bryan A Stevenson, Simeon J Smaill, et al.
Age and Ageing|June 24, 2021
Corrigendum to: Prevention of adverse drug reactions in hospitalized older patients with multi-morbidity and polypharmacy: the SENATOR* randomized controlled clinical trialDenis O'Mahony, Adalsteinn Gudmundsson, Roy L Soiza, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
European Geriatric Medicine|October 11, 2023
Authors' response to points raised by Boland et al. regarding STOPP/START version 3 criteriaDenis O'Mahony, Antonio Cherubini, Anna Renom Guiteras, et al.
European Geriatric Medicine|February 28, 2024
Response to letter by Masse O et al. STOPP/START version 3: clinical pharmacists are raising alarmsDenis O'Mahony, Antonio Cherubini, Anna Renom Guiteras, et al.
European Geriatric Medicine|May 31, 2023
STOPP/START criteria for potentially inappropriate prescribing in older people: version 3Denis O'Mahony, Antonio Cherubini, Anna Renom Guiteras, et al.
European Geriatric Medicine|June 16, 2023
Correction: STOPP/START criteria for potentially inappropriate prescribing in older people: version 3Denis O'Mahony, Antonio Cherubini, Anna Renom Guiteras, et al.
European Geriatric Medicine|June 10, 2026
Response to Boland et al. "Appraisal of the references supporting STOPP/START version 3 criteria"Denis O'Mahony, Antonio Cherubini, Anna Renom Guiteras, et al.
Stroke|July 3, 2010
Stroke subtype classification to mechanism-specific and undetermined categories by TOAST, A-S-C-O, and causative classification system: direct comparison in the North Dublin population stroke studyMichael Marnane, Caroline A Duggan, Orla C Sheehan, et al.
JAMA Network Open|July 27, 2022
Comparison of 6 Mortality Risk Scores for Prediction of 1-Year Mortality Risk in Older Adults With MultimorbidityClaudio Schneider, Carole E Aubert, Cinzia Del Giovane, et al.
European Geriatric Medicine|July 29, 2020
Association of polypharmacy and hyperpolypharmacy with frailty states: a systematic review and meta-analysisKatie Palmer, Emanuele R Villani, Davide L Vetrano, et al.
Global Change Biology|April 21, 2015
Effects of climate change on the delivery of soil-mediated ecosystem services within the primary sector in temperate ecosystems: a review and New Zealand case studyKate H Orwin, Bryan A Stevenson, Simeon J Smaill, et al.
Age and Ageing|June 24, 2021
Corrigendum to: Prevention of adverse drug reactions in hospitalized older patients with multi-morbidity and polypharmacy: the SENATOR* randomized controlled clinical trialDenis O'Mahony, Adalsteinn Gudmundsson, Roy L Soiza, et al.
Pageof 4